INS and diabetes mellitus: Butyrate is known to affect insulin sensitivity (Vrieze et al., 2012; Sanna et al., 2019), therefore, increased butyrate synthesis caused by an enhancement of the butyrate-producing intestinal bacteria is considered as one of the methods to prevent or treat diabetes (Zhang et al., 2021).